<p>Cells were either treated with EIPA, CytD and Wort for 1 hour or transfected with the dynamin mutant construct, DN dyn1K44A for 16–18 hours followed by human amylin incubation at either 100 nM or 10 µM for an additional 24 hours at 37°C. Dextran was sequentially added after incubating cells with 10 µM human amylin. Confocal microscopy (<b>A</b>) and whole cell analysis (<b>B–D</b>) showed no change in cellular distributions of monomers at 100 nM (B) or 10 µM (<b>C</b>) in the presence of EIPA, CytD, and Wort or DN dyn1K44A when compared to controls. NS P>0.1, hA vs. hA/treatments, n = 9. However, dextran (<b>D</b>) internalization was significantly reduced when treated with macropinocytotic inhibitors but not with DN dyn1K44A. <sup>##</s...
Intraneuronal accumulation of amyloid-? (A?) peptides represent an early pathological feature in Alz...
<p><b>(A),</b> Uptake of fluorescently-labelled 70kD dextran (green) in U2OS cells transfected with ...
<p>Effects of inhibitors (sucrose: clathrin-mediated endocytosis inhibitor; amiloride: macropinocyto...
<p>Cells were treated with EIPA, CytD, Wort or Dyn for 1 hour followed by human amylin (10 µM) incub...
<p>Cells were either treated with EIPA, CytD and Wort for 1 hour or transfected with dynamin mutant ...
<p>Cells were treated with EIPA, CytD, Wort or Dyn for 1 hour followed by human amylin (10 µM) incub...
<p>Cells were first treated with macropinocytotic inhibitors (EIPA, CytD or Wort) for 1 hour followe...
<p>Cells were first treated with macropinocytotic inhibitors (EIPA, CytD or Wort) for 1 hour followe...
<p>Cells were first treated with macropinocytotic inhibitors (EIPA, CytD or Wort) for 1 hour followe...
<p>(<b>A</b>) Human amylin (10 µM) was added to the cell culture media without (w/o) or containing c...
Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes me...
<div><p>Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 dia...
Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes me...
Intraneuronal accumulation of amyloid-? (A?) peptides represent an early pathological feature in Alz...
<p>(A) N2a cells were pretreated with either 100 µM EIPA or 5 mM cytochalasin D for 30 min prior the...
Intraneuronal accumulation of amyloid-? (A?) peptides represent an early pathological feature in Alz...
<p><b>(A),</b> Uptake of fluorescently-labelled 70kD dextran (green) in U2OS cells transfected with ...
<p>Effects of inhibitors (sucrose: clathrin-mediated endocytosis inhibitor; amiloride: macropinocyto...
<p>Cells were treated with EIPA, CytD, Wort or Dyn for 1 hour followed by human amylin (10 µM) incub...
<p>Cells were either treated with EIPA, CytD and Wort for 1 hour or transfected with dynamin mutant ...
<p>Cells were treated with EIPA, CytD, Wort or Dyn for 1 hour followed by human amylin (10 µM) incub...
<p>Cells were first treated with macropinocytotic inhibitors (EIPA, CytD or Wort) for 1 hour followe...
<p>Cells were first treated with macropinocytotic inhibitors (EIPA, CytD or Wort) for 1 hour followe...
<p>Cells were first treated with macropinocytotic inhibitors (EIPA, CytD or Wort) for 1 hour followe...
<p>(<b>A</b>) Human amylin (10 µM) was added to the cell culture media without (w/o) or containing c...
Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes me...
<div><p>Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 dia...
Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes me...
Intraneuronal accumulation of amyloid-? (A?) peptides represent an early pathological feature in Alz...
<p>(A) N2a cells were pretreated with either 100 µM EIPA or 5 mM cytochalasin D for 30 min prior the...
Intraneuronal accumulation of amyloid-? (A?) peptides represent an early pathological feature in Alz...
<p><b>(A),</b> Uptake of fluorescently-labelled 70kD dextran (green) in U2OS cells transfected with ...
<p>Effects of inhibitors (sucrose: clathrin-mediated endocytosis inhibitor; amiloride: macropinocyto...